Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Celldex Therapeutics (CLDX) Return on Assets (2016 - 2025)

Historic Return on Assets for Celldex Therapeutics (CLDX) over the last 15 years, with Q3 2025 value amounting to 0.33%.

  • Celldex Therapeutics' Return on Assets fell 1500.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.25% for FY2024, which is 900.0% up from last year.
  • Per Celldex Therapeutics' latest filing, its Return on Assets stood at 0.33% for Q3 2025, which was down 1500.0% from 0.28% recorded in Q2 2025.
  • In the past 5 years, Celldex Therapeutics' Return on Assets ranged from a high of 0.16% in Q4 2021 and a low of 0.43% during Q3 2023
  • Over the past 5 years, Celldex Therapeutics' median Return on Assets value was 0.27% (recorded in 2022), while the average stood at 0.27%.
  • In the last 5 years, Celldex Therapeutics' Return on Assets tumbled by -1700bps in 2023 and then skyrocketed by 2500bps in 2024.
  • Quarter analysis of 5 years shows Celldex Therapeutics' Return on Assets stood at 0.16% in 2021, then crashed by -100bps to 0.31% in 2022, then dropped by -22bps to 0.38% in 2023, then surged by 48bps to 0.2% in 2024, then crashed by -71bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 0.28% for Q2 2025, and 0.23% during Q1 2025.